05Feb 2021
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines

Advances in the development of personalized neoantigen-based therapeutic cancer vaccines

Within the past decade, the field of immunotherapy has revolutionized the treatment of many cancers with the development and regulatory approval of various immune-checkpoint inhibitors and chimeric antigen receptor T cell therapies in diverse indications.

  • #oncology

Like

Save

Share